2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on De-Escalation in Early Stage HER2+ BC: Should All Patients Receive Neoadjuvant Chemotherapy Just Because They Have HER2+ Disease? Can 6 vs. 12 Months of Anti-HER2 Therapy Be Equally Effective?

246 views
August 26, 2020
Comments 0
Login to view comments. Click here to Login